SUNSHINE LUXEMBOURG T/L B-3 (NESTLE / GALDERMA) (3/21)'s ticker is and the CUSIP is 0LX193531. A total of 1 filers reported holding SUNSHINE LUXEMBOURG T/L B-3 (NESTLE / GALDERMA) (3/21) in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,980,370 | +101.5% | 1,981,192 | +100.9% | 0.01% | +100.0% |
| Q2 2023 | $982,572 | +0.2% | 986,265 | -0.3% | 0.00% | 0.0% |
| Q1 2023 | $980,827 | +108.5% | 988,781 | +101.8% | 0.00% | +100.0% |
| Q4 2022 | $470,493 | +2.7% | 490,025 | -0.3% | 0.00% | -33.3% |
| Q3 2022 | $458,000 | 0.0% | 491,269 | -0.3% | 0.00% | 0.0% |
| Q2 2022 | $458,000 | -6.7% | 492,513 | -0.3% | 0.00% | -25.0% |
| Q1 2022 | $491,000 | -1.4% | 493,756 | -0.3% | 0.00% | -20.0% |
| Q4 2021 | $498,000 | – | 495,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pacer Advisors, Inc. | 1,981,192 | $1,980,370 | 0.01% |